Clinical Trials Browser

Enrolling by invitation × UNKNOWN × Clear all

NCT04762459 2022-02-24

APEX

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT04491721 2020-07-29

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse